Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors - PubMed (original) (raw)
Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors
M F van den Broek et al. J Virol. 1995 Aug.
Abstract
Alpha/beta interferon (IFN) and gamma IFN exert widely overlapping biological effects. Still, mice with individually inactivated alpha/beta or gamma receptors exhibit variably severely reduced resistance to infection and altered immune responses. To investigate to what extent the two IFN systems are functionally redundant, we generated mice with a combined receptor defect (AG129 mice). Like mice with individual mutations, AG129 mice had no apparent anomalies, confirming that in the mouse the IFN system is not essential for normal development. These mice showed an additive phenotype with respect to antiviral defense and exhibited an increased susceptibility to lymphocytic choriomeningitis virus (LCMV) and notably vaccinia virus infection. Because of unlimited replication and subsequent rapid exhaustion of cytotoxic T lymphocyte (CTL) precursors, these mice were unable to mount a CTL response to LCMV. CD8(+)-mediated immunopathology was absent in LCMV-infected mice, and virus persisted. Vaccinia virus replicated much faster in AG129 mice, and a 10(4)-fold lower dose of vaccinia virus was sufficient to prime these mice. With the normal priming dose of 10(6) PFU, cytopathic effects and overwhelming infection possibly causing partial exhaustion of CTL interfered with the anti-vaccinia virus response. Even though global antiviral immunoglobulin G (IgG) titers were within normal ranges, the IgG subclass distribution was heavily biased toward IgG1.
Similar articles
- Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice.
Leist TP, Eppler M, Zinkernagel RM. Leist TP, et al. J Virol. 1989 Jun;63(6):2813-9. doi: 10.1128/JVI.63.6.2813-2819.1989. J Virol. 1989. PMID: 2542591 Free PMC article. - Persistent virus infection despite chronic cytotoxic T-lymphocyte activation in gamma interferon-deficient mice infected with lymphocytic choriomeningitis virus.
Bartholdy C, Christensen JP, Wodarz D, Thomsen AR. Bartholdy C, et al. J Virol. 2000 Nov;74(22):10304-11. doi: 10.1128/jvi.74.22.10304-10311.2000. J Virol. 2000. PMID: 11044074 Free PMC article. - Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells.
Ou R, Zhou S, Huang L, Moskophidis D. Ou R, et al. J Virol. 2001 Sep;75(18):8407-23. doi: 10.1128/jvi.75.18.8407-8423.2001. J Virol. 2001. PMID: 11507186 Free PMC article. - Virus-induced acquired immune suppression by cytotoxic T cell-mediated immunopathology.
Zinkernagel RM. Zinkernagel RM. Vet Microbiol. 1992 Nov;33(1-4):13-8. doi: 10.1016/0378-1135(92)90031-n. Vet Microbiol. 1992. PMID: 1481353 Review. - Immune defence in mice lacking type I and/or type II interferon receptors.
van den Broek MF, Müller U, Huang S, Zinkernagel RM, Aguet M. van den Broek MF, et al. Immunol Rev. 1995 Dec;148:5-18. doi: 10.1111/j.1600-065x.1995.tb00090.x. Immunol Rev. 1995. PMID: 8825279 Review.
Cited by
- Adaptation of enterovirus 71 to adult interferon deficient mice.
Caine EA, Partidos CD, Santangelo JD, Osorio JE. Caine EA, et al. PLoS One. 2013;8(3):e59501. doi: 10.1371/journal.pone.0059501. Epub 2013 Mar 19. PLoS One. 2013. PMID: 23527208 Free PMC article. - Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
Matassov D, Marzi A, Latham T, Xu R, Ota-Setlik A, Feldmann F, Geisbert JB, Mire CE, Hamm S, Nowak B, Egan MA, Geisbert TW, Eldridge JH, Feldmann H, Clarke DK. Matassov D, et al. J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S443-51. doi: 10.1093/infdis/jiv316. Epub 2015 Jun 24. J Infect Dis. 2015. PMID: 26109675 Free PMC article. - Resistance to lethal ectromelia virus infection requires Type I interferon receptor in natural killer cells and monocytes but not in adaptive immune or parenchymal cells.
Melo-Silva CR, Alves-Peixoto P, Heath N, Tang L, Montoya B, Knudson CJ, Stotesbury C, Ferez M, Wong E, Sigal LJ. Melo-Silva CR, et al. PLoS Pathog. 2021 May 20;17(5):e1009593. doi: 10.1371/journal.ppat.1009593. eCollection 2021 May. PLoS Pathog. 2021. PMID: 34015056 Free PMC article. - Antiviral actions of interferons.
Samuel CE. Samuel CE. Clin Microbiol Rev. 2001 Oct;14(4):778-809, table of contents. doi: 10.1128/CMR.14.4.778-809.2001. Clin Microbiol Rev. 2001. PMID: 11585785 Free PMC article. Review. - Protective role of beta interferon in host defense against influenza A virus.
Koerner I, Kochs G, Kalinke U, Weiss S, Staeheli P. Koerner I, et al. J Virol. 2007 Feb;81(4):2025-30. doi: 10.1128/JVI.01718-06. Epub 2006 Dec 6. J Virol. 2007. PMID: 17151098 Free PMC article.
References
- Cell. 1990 Jan 26;60(2):225-34 - PubMed
- Adv Immunol. 1980;30:275-331 - PubMed
- Virology. 1991 Jul;183(1):419-22 - PubMed
- J Virol Methods. 1991 Jun;33(1-2):191-8 - PubMed
- J Exp Med. 1991 Nov 1;174(5):1179-88 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials